CareCloud Secures Credit Facility on Favorable Terms with Provident Bank to Support Medsphere Acquisition
CareCloud (NASDAQ: CCLD) has secured a new $10 million credit facility with Provident Bank, with approximately $8.3 million drawn at closing to support the recent Medsphere Systems Corporation acquisition. The facility, closed on September 3, 2025, replaces a previous Wells Fargo promissory note with more favorable terms.
The credit facility features an interest rate of SOFR plus 3% (currently under 7.5%) and a two-year term. This financing supports the $16.5 million Medsphere acquisition, of which $8.25 million was paid at closing from internal cash flow. CareCloud plans to fully pay down the Medsphere-related obligation by mid-2026 through internally generated cash flow.
CareCloud (NASDAQ: CCLD) ha ottenuto una nuova linea di credito da 10 milioni di dollari con Provident Bank; circa 8,3 milioni di dollari sono stati erogati al momento della chiusura per sostenere l'acquisizione di Medsphere Systems Corporation. La linea, finalizzata il 3 settembre 2025, sostituisce una precedente cambiale con Wells Fargo offrendo condizioni più favorevoli.
Il finanziamento prevede un tasso di interesse pari a SOFR più 3% (attualmente sotto il 7,5%) e una durata di due anni. Questa operazione supporta l'acquisizione di Medsphere da 16,5 milioni di dollari, di cui 8,25 milioni sono stati versati alla chiusura con liquidità interna. CareCloud prevede di estinguere completamente l’esposizione legata a Medsphere entro la metà del 2026 utilizzando flussi di cassa interni.
CareCloud (NASDAQ: CCLD) ha asegurado una nueva línea de crédito de 10 millones de dólares con Provident Bank, con aproximadamente 8,3 millones de dólares desembolsados al cierre para respaldar la adquisición de Medsphere Systems Corporation. La línea, cerrada el 3 de septiembre de 2025, reemplaza un pagaré anterior con Wells Fargo con términos más favorables.
La financiación tiene un tipo de interés de SOFR más 3% (actualmente por debajo del 7,5%) y un plazo de dos años. Este financiamiento respalda la adquisición de Medsphere por 16,5 millones de dólares, de los cuales 8,25 millones se pagaron al cierre con efectivo interno. CareCloud planea liquidar por completo la deuda relacionada con Medsphere a mediados de 2026 con flujo de caja interno.
CareCloud (NASDAQ: CCLD)는 Provident Bank와 새로운 1,000만 달러 신용 한도를 체결했으며, Medsphere Systems Corporation 인수를 지원하기 위해 종결 시점에 약 830만 달러를 인출했습니다. 이 대출은 2025년 9월 3일 마감되었으며, 더 유리한 조건의 기존 Wells Fargo 약속어음을 대체합니다.
신용 한도는 SOFR 플러스 3% (현재 7.5% 미만)의 금리와 2년 만기를 특징으로 합니다. 이 자금은 1,650만 달러 규모의 Medsphere 인수를 지원하며, 그중 825만 달러는 내부 현금으로 종결 시 지급되었습니다. CareCloud는 내부 현금 흐름을 통해 2026년 중반까지 Medsphere 관련 채무를 전액 상환할 계획입니다.
CareCloud (NASDAQ: CCLD) a obtenu une nouvelle ligne de crédit de 10 millions de dollars auprès de Provident Bank, avec environ 8,3 millions de dollars tirés à la clôture pour soutenir l’acquisition de Medsphere Systems Corporation. La facilité, finalisée le 3 septembre 2025, remplace une précédente reconnaissance de dette chez Wells Fargo avec des conditions plus avantageuses.
La ligne prévoit un taux d’intérêt de SOFR plus 3% (actuellement inférieur à 7,5%) et une durée de deux ans. Ce financement soutient l’acquisition de Medsphere pour 16,5 millions de dollars, dont 8,25 millions ont été payés à la clôture avec des fonds internes. CareCloud prévoit d’apurer entièrement l’obligation liée à Medsphere d’ici la mi-2026 grâce aux flux de trésorerie internes.
CareCloud (NASDAQ: CCLD) hat eine neue Kreditlinie über 10 Millionen US-Dollar bei Provident Bank gesichert; beim Abschluss wurden rund 8,3 Millionen US-Dollar abgerufen, um die Übernahme von Medsphere Systems Corporation zu unterstützen. Die Vereinbarung, abgeschlossen am 3. September 2025, ersetzt ein früheres Schuldscheindarlehen mit Wells Fargo zu günstigeren Konditionen.
Die Kreditlinie sieht einen Zinssatz von SOFR plus 3% (derzeit unter 7,5%) und eine Laufzeit von zwei Jahren vor. Die Finanzierung dient der 16,5 Millionen US-Dollar schweren Übernahme von Medsphere, von der 8,25 Millionen bei Abschluss aus internen Mitteln bezahlt wurden. CareCloud plant, die Medsphere-bezogene Verbindlichkeit bis Mitte 2026 vollständig aus internem Cashflow zu tilgen.
- New credit facility offers lower interest rate (under 7.5%) compared to previous Wells Fargo note
- Strong cash position demonstrated by $8.25M cash payment for acquisition from internal funds
- Strategic acquisition of Medsphere Systems worth $16.5M enhances market position
- Improved financial flexibility with more favorable borrowing terms
- Additional debt of $8.3M taken on through the credit facility
- Obligation to repay significant acquisition-related debt by mid-2026
Insights
CareCloud secured favorable $10M credit facility for Medsphere acquisition, improving liquidity and lowering borrowing costs.
CareCloud has secured a
The new facility offers three key financial advantages: 1) A more competitive interest rate of SOFR plus
What's particularly noteworthy is CareCloud's capital allocation strategy. The company paid
This refinancing signals confidence from institutional lenders in CareCloud's financial health while strategically positioning the company with improved debt terms. By replacing the Wells Fargo promissory note entirely, management has effectively restructured their debt profile to support their acquisition strategy while maintaining financial flexibility. The favorable terms suggest strong negotiating leverage and lender confidence in the company's growth trajectory and cash flow generation capabilities.
New Facility Replaces Prior Acquisition-Related Promissory Note Obligation to Wells Fargo; Provides More Favorable Terms and Strengthens Liquidity while Supporting Future Growth
SOMERSET, N.J., Sept. 09, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in healthcare technology and AI-powered solutions for hospitals and medical practices nationwide, today announced it has closed a new
“Our new credit facility provides CareCloud with improved flexibility, a lower cost of borrowing, and the financial strength to continue executing on our strategy,” said Norm Roth, Interim Chief Financial Officer of CareCloud. “This new facility will further support the recent Medsphere acquisition, which had a total purchase price of
The Provident facility currently bears an interest rate of SOFR plus
Additional details regarding the Provident facility are available in CareCloud’s Form 8-K, which is being filed today.
About CareCloud
CareCloud brings disciplined innovation to the business of healthcare. Our suite of AI and technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care, while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health, at carecloud.com.
Follow CareCloud on LinkedIn, X and Facebook.
For additional information, please visit our website at carecloud.com. To listen to video presentations by CareCloud’s management team, read recent press releases and view the latest investor presentation, please visit ir.carecloud.com.
Forward-Looking Statements
This press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “might,” “will,” “shall,” “should,” “could”, “intends,” “expects,” “plans,” “goals,” “projects,” “anticipates,” “believes,” “seeks,” “estimates,” “predicts,” “possible,” “potential,” “target,” or “continue” or the negative of these terms or other comparable terminology.
Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, and the expected results from the integration of our acquisitions. Past operational or stock price performance is not an indication of future performance.
These forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry’s) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to the Company’s ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards, compete with other companies’ products and services competitive with ours, and other important risks and uncertainties referenced and discussed under the heading titled “Risk Factors” in the Company’s filings with the Securities and Exchange Commission.
The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.
SOURCE: CareCloud
Company Contact:
Norman Roth
Interim Chief Financial Officer and Corporate Controller
CareCloud, Inc.
nroth@carecloud.com
Investor Contact:
Stephen Snyder
Co-Chief Executive Officer
CareCloud, Inc.
ir@carecloud.com
